This application claims priority to Chinese Patent Application No. 202310744875.1, filed on Jun. 21, 2023, the contents of which are hereby incorporated by reference.
The present application belongs to the technical field of intelligent bracelet design, and in particular to an intelligent bracelet capable of injecting medications.
Recent years see a growing number of people aged over 70 suffering from cardiovascular diseases as the global population ages, and it has been found in research that the vast majority of these people live alone most of the time and have companionship occasionally with their children on holidays. Most senior citizens have difficulty in operating smart devices due to blurred vision and shaky hands. Usually once feeling unwell, old people take first-aid medications, such as quick-acting heart pills or sublingual nitroglycerin, by oral administration and then seek further first aids. However, self-rescue options such as calling an emergency service or calling out for help to those around them are not possible when old people suffer sudden cardiovascular syncope. It is difficult for people to save themselves from a cardiovascular attack and the probability of being found and helped by others is low, and doctors find great difficulties in taking rescue measures, resulting in untimely and ineffective rescue.
It is an objective of the present application to provide an intelligent bracelet capable of injecting medications in order to solve the above-mentioned problems of the prior art.
To achieve the above objective, the present application provides an intelligent bracelet capable of injecting medications, including a multi-modal sensor assembly, a main control chip, a medication injection device and a bracelet display interface;
the multi-modal sensor assembly, the medication injection device and the bracelet display interface are connected with the main control chip;
the multi-modal sensor assembly is configured to acquire physical data of a wearer;
the main control chip includes a processor, a memory, a communication interface and a digital interface, and the main control chip is configured to detect abnormal physical conditions by adopting a machine learning method according to the physical data;
the medication injection device is configured to inject medications to the wearer when the abnormal physical conditions are detected; and
the bracelet display interface is configured to display the physical data and corresponding danger levels.
Optionally, the multi-modal sensor assembly further includes an inertial measurement unit (IMU), and the inertial measurement unit is configured to identify a fall of a human body, and the physical data includes heart rate and oxyhemoglobin saturation.
Optionally, the IMU adopts a fall detection algorithm model of long short-term memory (LSTM) for fall identification, including steps like sensor data acquiring, data preprocessing, feature extracting, threshold detecting, machine learning classifying, fall judging, posture analyzing, and warning and responding.
Optionally, early warning measures are activated when the multi-modal sensor assembly detects that a heart rate of the wearer is below 40 or above 160 and the oxyhemoglobin saturation is below 92% within 30 seconds, and a fall is detected from the wearer in the meantime.
Optionally, the early warning measures include: the bracelet display interface automatically pops up a display of a countdown for 30 seconds and simultaneously makes a sound of an alarm; if the wearer does not cancel the countdown by himself, the medication injection device is activated and the wearer is given an intramuscular injection of adrenaline; and
if the wearer cancels the countdown by himself, no medication injection is carried out, and a log of this event is recorded and the bracelet resumes to a normal state.
Optionally, the main control chip includes fall detection software, and the fall detection software adopts a pre-trained deep learning algorithm to optimize the fall detection algorithm model for performance in terms of a correct detection rate and a false alarm rate; and
a method of the pre-trained deep learning algorithm includes principal component analysis (PCA), linear discriminant analysis (LDA), over-sampling, transfer learning, online learning, model compression technology, cost function or decision threshold adjustment, data set fine adjustment, sensor sampling rate optimization, data processing and feature extraction pipeline.
Optionally, a home page of the bracelet display interface displays a current heart rate and a blood oxygen concentration of the wearer, with different colors indicating different physical danger levels; and
the danger levels include the highest danger, secondary danger and no danger, which are displayed in red, orange and green respectively.
Optionally, when the wearer is in the secondary danger, the bracelet display interface pops up an “SOS” interface for the wearer to determine whether to report an alarm; when the wearer is in a state of the highest danger, the medication injection device is automatically triggered to inject the medications.
The application has the technical effects that:
based on the functions of the existing intelligent bracelet, the present application incorporates the design of an injection system of micro-electro-mechanical system (MEMS), enabling the device to automatically detect the wearer's physical indicators and abnormal states, and to automatically inject epinephrine medications and automatically give an alarm at the same time, which helps improve the efficiency of the current cardiovascular disease emergency aid and develop a more effective medication delivery system; further, the present application enables the automatic injection of emergency medications and the simultaneous automatic alarm to save lives as well as medical and health resources.
The accompanying drawings which form part of this application are used to provide a further understanding of this application and the schematic embodiments of this application and the description thereof are used to explain this application and do not constitute an improper limitation of this application.
The FIGURE is a process illustrating a specific application of an intelligent bracelet capable of injecting medications provided by an embodiment of the present application.
It should be noted that the embodiments in this application and the features in the embodiments may be combined with each other without conflict. The present application is described in detail with reference to the drawings and embodiments.
It is noted that the steps illustrated in the process diagram of the accompanying drawings are executable in a computer system such as a set of computer-executable instructions and, although a logical sequence is illustrated in the process diagram, in some instances the steps shown or described may be executed in an order different from that shown herein.
As shown in the FIGURE, an intelligent bracelet capable of injecting medications is provided in this embodiment, including a multi-modal sensor assembly, a main control chip, a medication injection device and a bracelet display interface; among them:
the multi-modal sensor assembly is configured to acquire physical data of a wearer;
the main control chip includes a processor, a memory, a communication interface and a digital interface, and the main control chip is configured to detect abnormal physical conditions are by adopting a machine learning method according to the physical data;
the medication injection device is configured to inject medications to the wearer when abnormal physical conditions are detected; and
the bracelet display interface is configured to display the physical data and corresponding danger levels.
The hardware and software modules and sensors in a system of the intelligent bracelet are required to be connected and controlled via the main control chip to achieve an overall functionality of the system.
The main control chip is the core of the intelligent bracelet system and is responsible for controlling and managing the various hardware modules and sensors, as well as processing and storing data. The main control chip usually integrates functions of a processor, a memory and a communication interface and is able to communicate with other hardware modules and sensors through various digital interfaces.
Various hardware modules are connected to a software system (including detection data and control signals. Typical digital interfaces include Inter-Integrated Circuit (I2C), Serial Peripheral Interface (SPI), and Universal Asynchronous Receiver/Transmitter (UART), etc.
Medication injection device-MEMS is an executive hardware module connected with the main control chip through digital interface.
The bracelet display interface, typically a liquid crystal display (LCD), is controlled by a display controller integrated with the main control chip.
The intelligent bracelet is embedded with a multi-modal physiological indicator abnormality and fall detection software as a core, which uses a machine learning algorithm model that can process heterogeneous source data from the multi-modal sensor assembly of the bracelet, relying on a pre-trained deep learning model to automatically detect patient physiological indicator abnormalities and fall postures in only a few fall samples, and give instructions to inject medications after autonomously determining that the patient is in imminent danger. It is configured for two different scenarios.
The multi-modal sensor assembly detects that:
the heart rate of the wearer is below 40 or above 160;
the oxyhemoglobin saturation of the wearer is below 92% (of a dangerous blood oxygen range); and
the inertial measurement unit (IMU) of the intelligent bracelet detects “falling”, that is, the body suddenly leans or falls.
If all three of these indicators are detected within 30 seconds, the bracelet interface automatically pops up a 30-second countdown display and gives an alarm at the same time. If the wearer does not cancel the countdown by himself, the sensor on the intelligent bracelet automatically sends a signal to activate the medication injection device for an intramuscular injection of adrenaline; and
if the wearer cancels it by himself, the software of the intelligent bracelet gives no instruction to inject the medications and a log of this event is recorded and the bracelet returns to its normal state.
The fall detection algorithm model of long short-term memory (LSTM) of the intelligent bracelet, which is fine-tuned and optimized with a small number of samples, distinguishes a fall from a normal physical movement of the patient, with following working steps:
Considering the small sample amount of fallen body posture data from elderly patients in the real scenarios, the detection model uses pre-trained deep learning algorithms to improve the performance of the model in the following aspects, including key indicators such as a correct detection rate and a false alarm rate.
In summary, improving fall detection models on wearable devices requires a combination of strategies, including careful data pre-processing, feature engineering, model selection, performance optimization and user-centred design, and by implementing these techniques and continuously evaluating models in practical scenarios, more accurate and reliable fall detection systems can be constructed.
An example of LSTM model for fall detection process:
The home screen of the bracelet displays the wearer's current heart rate and oxyhemoglobin concentration, with different colors indicating the current danger level of the body (red for the highest danger 03, orange for the secondary danger 02 and green for the no danger 01). If the wearer feels unwell, or is in danger level 02, it is up to the wearer to decide if an alarm is required (the wearer needs to slide up the screen to pop up the “SOS” screen, but it does not activate the automatic injection process. The medication injection device is only activated automatically under state 03.
What has been described above represents only the specific embodiments of the present application, but the scope of protection of the present application is not limited to it. Any variation or substitution that may be readily thought of by any person skilled in the art within the technical scope disclosed by the present application should be covered by the scope of protection of the present application. Therefore, the scope of protection of this application should be subject to the scope of protection of the claims.
Number | Date | Country | Kind |
---|---|---|---|
202310744875.1 | Jun 2023 | CN | national |